QQ登录

只需一步,快速开始

登录 | 注册 | 找回密码

三维网

 找回密码
 注册

QQ登录

只需一步,快速开始

展开

通知     

全站
goto3d 说: 版主微信号:caivin811031;还未入三维微信群的小伙伴,速度加
2022-07-04
全站
goto3d 说: 此次SW竞赛获奖名单公布如下,抱歉晚了,版主最近太忙:一等奖:塔山817;二等奖:a9041、飞鱼;三等奖:wx_dfA5IKla、xwj960414、bzlgl、hklecon;请以上各位和版主联系,领取奖金!!!
2022-03-11
查看: 1807|回复: 0
收起左侧

[医药] The Cancer Handbook(癌症手册)[英语]

 关闭 [复制链接]
发表于 2007-8-12 09:52:34 | 显示全部楼层 |阅读模式

马上注册,结识高手,享用更多资源,轻松玩转三维网社区。

您需要 登录 才可以下载或查看,没有帐号?注册

x
《The Cancer Handbook(癌症手册)》" J" V! C& e3 \' W2 v# c8 t
# C( z) J! n& Z+ }% f
全书PDF格式,27.3M,高清晰,共13个压缩包。9 [) s3 \" r' U/ U, p0 _" I0 E. D. Q$ M
1.jpg * ]' m, t* S6 G% ?" y9 s
癌症手册提供关于癌症生物学和医学所有主要领域的科学和临床信息的综合概述,它与现有肿瘤学教程和参考资料的不同在于,癌症手册弥补了癌症分子生物学与临床诊断与治疗之间的差距。0 g0 l3 Z+ M) }2 M1 z6 i
涉及广泛的学科-从基本细胞生物学到所有主要器官和组织的系统肿瘤学-癌症手册的内容组织成六个主要部分:5 _% e8 i+ y4 ^! v9 @& j: A7 n
• 细胞和组织的分子基础6 P! Q( N- S- U/ l& B- J
• 癌症的原因和预防& B1 F* I7 E5 k
• 诊断显象和影像-引导的乾涉
3 v8 w) b8 [3 f& J2 o  a4 L• 系统肿瘤学' R0 f, `- A% N4 {, R/ \. w) f2 `
• 人类癌症的预诊断模式
- j; {8 A' j) }/ W• 人类癌症的治疗
9 H( D1 C4 S/ g$ T' C; i8 N6 d4 h& W* f
对于医学和生命科学学生以及所有在癌症领域和相关生物医学领域工作的科学工作者、临床医师和研究工作者来说,这本书是不可缺少的资源。/ z: ?+ K' r+ p$ V& ~+ X
) Y. W; C& ^, n: ]0 {$ g+ F' ^
目录( v" F2 |0 _* `/ s
Section A - The Molecular Basis of Cell and Tissue Organization1 h1 w5 I* W+ k3 G. [- \
1. Cell and Tissue Organisation0 N4 A6 r# {8 }& m1 r2 e$ `
2. Regulation of the Cell Cycle
2 Z0 l: Z- a/ x: t( O4 ?% R; m+ {3. Overview of Oncogenesis$ _( P; F; j6 ]" q$ a7 ^* n2 L8 b7 R
4. Inherited Predispositions to Cancer" i) m6 h7 O: ?" Z7 S5 v, p* w
5. DNA Viruses3 E1 }* _# \: \4 X2 s/ u/ b8 o
6. RNA Viruses4 V% k3 w6 [. D3 {
7. Genetic Instability and DNA repair/ ?/ i9 V4 Q- H+ \0 i2 Z
8. Telomerase9 B, d, h$ f6 x' }; K# h
9. Apoptosis
% A$ h; ?  D; m) r% n10. Signalling by steroid receptors
, \+ o/ N+ Q& z; s1 }  o, E3 l2 M11. Signalling by cytokines0 W9 e2 ]; K2 p% U# Y. W
12. Signalling by tyrosine kinases( g5 |: j+ k1 T. Q4 O
13. Signalling by TGF beta: F5 m2 P; E& |- y8 L' Q7 A
14. Wnt Signal Transduction; r% u4 ?1 ?+ p2 s- ~% E
15. Extracellular Matrix: the networking solution. i! |% l, ?( e+ {7 T4 B
16. Invasion and Metastasis0 `+ i" q+ W- G# j
17. Angiogenesis! B$ u3 E) J% T
18. Cell Proliferation in Carcinogenesis
' ^, F, G9 N' d" d) bSection B - The Causation and Prevention of Cancer
3 i8 ]" w: {; X. h6 W) M* N1. Identifying Cancer Causes through Epidemiology
0 Q8 y: h" z9 B3 f0 E* K5 X( U2. Mechanisms of Chemical Carcinogenesis
$ `# B0 B& v1 X# Z! d: P3. The Formation of DNA Adducts
& ^! ~9 ]# k: ^4. Physical Causes of Cancer1 S) A+ V8 _: Z+ `  y5 j! h
5. Non-Genotoxic Causes of Cancer) {. W6 P9 R) j2 O" B- ?
6. Infectious Agents and Cancer' ^9 @* E/ p0 {% E
7. Short-term Testing for Genotoxicity0 k+ z9 x* K4 F2 Y! J1 g* C7 j/ _) j
8. Cancer Bioassays for Pharmaceuticals a Regulatory Perspective' y7 J. k& R2 q% a! j
9. Molecular Epidemiology of Cancer
# {" t; u5 \/ I# J; {; O10. Dietary Genotoxins and Cancer
- r+ P5 T# A9 {4 J# @0 _3 v11. Tobacco Use and Cancer+ I7 \' V2 S9 p3 U& j
12. Occupational Causes of Cancer
5 H; A* Y2 A# M8 L9 }3 e13. Anti-Genotoxins and Cancer
7 N* y# p0 O2 q. f# H7 w0 U2 @14. Intervention and Chemoprevention& P/ \6 v9 s  |3 b
Section C - Diagnostic Imaging and Image-Guided Intervention# \2 e0 M* B5 V% R$ _' O; f
Part I- Imaging Modalities in Diagnosis and Monitoring- W: G9 T" h( t8 c  _  B
1. Plain Film Radiography9 Y+ I. N4 X) b
2. Computed Tomography
6 Q3 a, U8 n2 M, l* W7 q3. Ultrasound
: K; k& r* ?- {* F) W) D# X+ d+ @4. Magnetic Resonance Imaging$ O( S7 U2 c; n+ \
5. Nuclear Medicine Studies
8 O! [: A' G/ W! }. j9 }: ]" T6 L6. Mammography, }' k+ f' ~/ m4 f1 V' r
Part II - Diagnostic and Therapeutic Interventional Procedures0 n# W' f1 l/ _6 Q( r
1. Percutaneous Biopsy
, ^$ F  e+ w4 r2. Transcatheter Therapy$ ]! P! s6 |1 N! T
3. Direct Percutaneous Tumour Therapy
; f" L: h0 v9 U4 b+ Z' SSection D - Systemic Oncology
8 y+ U4 s7 J# @5 u# S1. Introduction to the Diagnosis of Cancer  V& c" K5 G: P5 y9 H1 d
2. Skin6 J% v% L0 L" C+ S
3. Oral cavity & major and minor salivary glands
1 P$ R1 L9 Y% U4 F; D4. Respiratory tract
% c; K$ P3 v' [" z1 n5. Upper Gastrointestinal tract) i9 K" P: m8 U6 V& F/ z: w
6. Lower gastrointestinal tract- |- X$ M0 e- E. c' `5 B5 b; |
7. Liver, gall bladder and extrahepatic bile ducts.
3 H. u7 L0 m# |0 G7 l8. Pancreas
1 Y2 \' c9 d: f% y% E0 S+ i9. Endocrine organs5 f7 ]& F) {) x; d
10. Breast8 W' d( ?* i0 P0 M$ g* K
11. Female reproductive system$ I3 L8 y. j% @1 {
12. Urinary tract
$ A1 D* D/ L+ D8 W9 Q7 M5 }13. Male reproductive system8 C1 G( G$ m: V: v5 g
14. Lymph nodes, spleen and bone marrow.
9 Y1 a' ?6 L! b* b15. Bones and joints.
( T, r+ K; F- l" s, b6 W16. Soft Tissues
6 ^' A8 H% I0 Y+ b2 x+ ^17. Pleura and peritoneum
. T5 @. `' H" u7 U0 ^, Q( v' k4 _18. Heart
3 g3 E& @2 e* ?- n19. Neuromuscular System
' ^% K3 T3 y0 G8 O2 ?8 A/ o5 p" a20. Eye and ocular adnexa
0 Z, Z0 u6 w' z* G  x; `% v21. Ear$ W: o' v/ Z  M/ s  l5 J
Appendum. Myeloid Leukemias and related Neoplasms$ Q: A; N) i3 f7 M) M- ~/ U
Section E - Pre-clinical Models of Human Cancer- F% P/ |6 y; F' V* r! @
1. Advantages and limitations of models for human cancer
' W8 d3 H. B9 `2 X' Y5 ?" _# i0 |2. Basic Tissue Culture
4 ~$ v8 C$ m8 G7 ~& z3 n9 P+ n3. Transgenic technology in the study of oncogenes and Tumor Suppressor Genes
) g' }9 l7 s- ?8 P4 s4. Gene knockouts
5 ^8 {( e& D$ Y$ x# X9 |5. Human tumours in animal hosts
  H# |- Z5 V9 q& O  u; v+ G6. Mammary tumour induction in animals as a model for human breast cancer
0 y! Y  C& B( L& M! [7. Mathematical models in cancer research8 l# I* q6 x  X
8. Models for tumour growth and differentiation
2 A" B6 _" N* v  g9. Angiogenesis models
: h4 `- A* W. I4 [1 Y( M7 v* w7 r; W" t4 u10. Models for tumour cell adhesion and invasion1 T( A" X/ H& ?, B/ b  E) [
11. Tumour metastasis models6 S, U. w7 A/ J+ B" U
12. Models for tumour cell-endothelial cell interactions( T( E( o7 \5 y7 [2 i
13. Modelling Tumor Tissue Interactives
  }7 I. s" g2 Q% Q; T: ^% m14. Models for drug development and drug resistance
1 X) C8 A2 }, w2 m5 N15. Models for immunotherapy and cancer vaccines
3 r1 g4 ~# {+ y1 g16. Gene therapy models5 ]. K1 Q9 f7 b' ]9 z% b
17. Models for epithelial carcinomas/ @' \3 u: T' d; t+ M1 g* _
18. Models for haematological malignancies
. O( ]+ t; z. _- }. U: m19. Models for melanomas and sarcomas
% Q, k% I$ y0 |/ l; P20. Models for CNS malignancies: W4 H* S" E" G8 a4 }
21. Models for endocrine cancer
8 ]; t9 d0 W% q; V4 V+ TSection F - The Treatment of Human Cancer8 e( n9 Z: c8 \9 D
1. Mechanisms of action of cancer chemotherapeutic agents
; n% M9 Y7 c; {& @2. Drug Resistance & Reversal
0 c4 t, k+ V) j5 k4 }3. Molecular mechanisms of radiotherapy* H/ M2 d9 R% @$ L) E  q: `8 b; {
4. Antibodies and recombinant cytokines! [6 x& `5 ?/ {6 \/ c# a2 U, x- t
5. Genetic and Cellular Vaccines
9 o2 T. Y! K! @9 e% y6. Differentiation Therapy- h+ o' i2 z! S# h& C6 h0 Y
7. Chemoprevention
, R' x* n' V2 j& O8 D8. Antisense & ribozyme therapy# k* r0 Z" t  j: e% o
9. Hormonal Therapy. G2 L& ]+ n- k6 a+ {
10. Antiangiogenic Therapy0 k# q5 ?- \- b0 e. C- ^
11. Targeting the Extracellular Matrix' f9 t: q% I2 _( D' Z9 _1 ]
12. Growth Factor Receptor Blockade) I  X, w2 z9 K
13. Signal
: Y4 A1 A3 z4 l5 }" I- w9 t( U: J2 {1 |/ a2 V
[ 本帖最后由 清风明月008 于 2007-8-12 10:32 编辑 ]

The.Cancer.Handbook.part01.rar

1.95 MB, 下载次数: 16

The.Cancer.Handbook.part02.rar

1.95 MB, 下载次数: 15

The.Cancer.Handbook.part03.rar

1.95 MB, 下载次数: 16

The.Cancer.Handbook.part04.rar

1.95 MB, 下载次数: 15

The.Cancer.Handbook.part05.rar

1.95 MB, 下载次数: 15

The.Cancer.Handbook.part06.rar

1.95 MB, 下载次数: 15

The.Cancer.Handbook.part07.rar

1.95 MB, 下载次数: 16

The.Cancer.Handbook.part08.rar

1.95 MB, 下载次数: 16

The.Cancer.Handbook.part09.rar

1.95 MB, 下载次数: 15

The.Cancer.Handbook.part10.rar

1.95 MB, 下载次数: 15

The.Cancer.Handbook.part11.rar

1.95 MB, 下载次数: 15

The.Cancer.Handbook.part12.rar

1.95 MB, 下载次数: 15

The.Cancer.Handbook.part13.rar

1.68 MB, 下载次数: 16

评分

参与人数 1三维币 +10 收起 理由
z6z6j6 + 10 多本资料奖励

查看全部评分

发表回复
您需要登录后才可以回帖 登录 | 注册

本版积分规则

Licensed Copyright © 2016-2020 http://www.3dportal.cn/ All Rights Reserved 京 ICP备13008828号

小黑屋|手机版|Archiver|三维网 ( 京ICP备13008828号-1 )

快速回复 返回顶部 返回列表